FRUNZE D. , CIUBOTARU A. , MANIUC L. , GUZGAN I. , CORCEA V. , BOTIZATU A. , BORSEVSCHI V. , REPIN O.
SCR .CISHINAU.REPUBLICA MOLDOVA;OBJECTIVES: Transfusion of blood components in cardiac interventions represents a risk factor in the development of anaphylaxis and pulmonary complications (ALI / ARDS). In this context the experience of reduced administration of blood component was analyzed in the early post CPB period. MATERIALS AND METHODS: Of all patients operated during 2015-2016 there was studied a group of 100 patients with congenital heart defects aged 1 months to 1 year with body mass from 3 to 9 kg, CPB length 20-180 minutes ,who were administered antifibrinolytic medication (ac.tranexamic, ac.aminocapronic, aprotinin) and was not given fresh frozen plasma, cryoprecipitate and platelets. RESULTS:Mortality - 0%,Anafilactic reactions - 0%,ALI / ARDS - 0%,Reoperations for hemostasis 0% Average length of stay in intensive care unit - 40 hours. CONCLUSIONS: The restriction of routinely transfusion of blood components in cardiac interventions reduces the risk of developing complications of adverce reactions, pulmonary (ALI / ARDS) and reduce the cost interventions.